NCT00158717View on ClinicalTrials.gov

Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.

CompletedOBSERVATIONAL
Enrollment

107

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
Hepatitis B
Interventions
DRUG

Hepsera

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY